Researcher.Life Logo

Thoracic Cancer : Impact Factor & More

eISSN: 1759-7714pISSN: 1759-7706
JournalOpen Access

Key Metrics

CiteScore
4.2
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Thoracic Cancer

Thoracic Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Semi-monthly
Article Processing ChargesUSD 2000
Publication Time41
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorChina Lung Oncology Group
FrequencySemi-monthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 41
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Thoracic Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Thoracic Cancer

Margin Quality Analysis and Risk Factors Associated With Insufficient Margins Following Segmentectomy for Small\u2010Sized Non\u2010Small Cell Lung Cancer
  • 15 May 2026
  • Thoracic Cancer
Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021
  • 15 May 2026
  • Thoracic Cancer
Impact of Anti\u2010Inflammatory Drug Therapy on the Efficacy of First\u2010Line Atezolizumab Treatment in Patients With Advanced Non\u2010Small Cell Lung Cancer: An Integrated Analysis of Five Randomized Controlled Trials
  • 15 May 2026
  • Thoracic Cancer
Perioperative Normobaric Hyperoxia Combined With Pulmonary Rehabilitation Intervention for Enhanced Short\u2010Term Recovery in Lung Cancer Surgery
  • 12 May 2026
  • Thoracic Cancer
Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune-Checkpoint Inhibitors.
  • 1 May 2026
  • Thoracic cancer
Extended Indications for Sleeve Lobectomy: A Single-Center Experience of Surgical Management of Central Pulmonary Metastases.
  • 1 May 2026
  • Thoracic cancer
Margin Quality Analysis and Risk Factors Associated With Insufficient Margins Following Segmentectomy for Small\u2010Sized Non\u2010Small Cell Lung Cancer
  • 15 May 2026
  • Thoracic Cancer
Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021
  • 15 May 2026
  • Thoracic Cancer
Impact of Anti\u2010Inflammatory Drug Therapy on the Efficacy of First\u2010Line Atezolizumab Treatment in Patients With Advanced Non\u2010Small Cell Lung Cancer: An Integrated Analysis of Five Randomized Controlled Trials
  • 15 May 2026
  • Thoracic Cancer
Perioperative Normobaric Hyperoxia Combined With Pulmonary Rehabilitation Intervention for Enhanced Short\u2010Term Recovery in Lung Cancer Surgery
  • 12 May 2026
  • Thoracic Cancer
Rethinking Invasive Mediastinal Staging in the Era of Neoadjuvant Immune-Checkpoint Inhibitors.
  • 1 May 2026
  • Thoracic cancer
Extended Indications for Sleeve Lobectomy: A Single-Center Experience of Surgical Management of Central Pulmonary Metastases.
  • 1 May 2026
  • Thoracic cancer

FAQs on Thoracic Cancer